Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Tamsulosin · 1 trial · 4 indications
Failed voiding trial upon removal of catheter
| Arm | Type | Description |
|---|---|---|
| Placebo | PLACEBO_COMPARATOR | - |
| Tamsulosin | EXPERIMENTAL | - |
| Name | Type | Description |
|---|---|---|
| Placebo oral capsule | DRUG | Tamsulosin or placebo will be given for 3 days prior to surgery and one week after surgery to determine its effects on postoperative urinary retention. |
| Tamsulosin | DRUG | Tamsulosin or placebo will be given for 3 days prior to surgery and one week after surgery to determine its effects on postoperative urinary retention. |
Inclusion Criteria: * Patients must be 18 years or older as well as willing and able to provide informed consent * Patients must be undergoing a scheduled surgery for pelvic organ prolapse or urinary incontinence * Standard postoperative plan must include admission to the hospital with foley cathet...